Erectile Dysfunction Market, By Application (Parenteral and Oral), By Therapy Type, By Product Type, By Distribution Channel, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4499
|
Published Date
November 2025
|
Pages
397
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Erectile Dysfunction Market size was valued at US$ 2,567.87 Million in 2024, expanding at a CAGR of 8.2% from 2025 to 2032.
Erectile dysfunction (ED) is defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity. This complex condition can stem from vascular, neurological, hormonal, or psychological causes, and it significantly affects men’s physical and emotional wellbeing. One of the key drivers of the ED treatment market is the rising global burden of chronic diseases—especially cardiovascular disorders and diabetes —both of which greatly increase the risk of ED. Sedentary lifestyles, stress, and other modern health pressures further compound the problem.
On the other hand, the market is constrained by the expiration of patents for blockbuster ED drugs like Viagra and Cialis, which has triggered steep price drops and intense competition from generics. Yet, modern trends are bringing fresh opportunities: next-generation oral therapies, stem-cell–based interventions, and digital health platforms that offer private online consultations and prescriptions are gaining traction. These innovations, together with growing societal acceptance of sexual wellness as a vital part of men’s health, are expected to drive long-term growth and modernization in the ED market. Government investment in male reproductive health is increasing, albeit from a relatively low base. For example, in the U.S., the National Institute of Child Health and Human Development (NICHD) funded US$39.5million for male reproductive health research in 2019, representing about 0.26% of its total research budget. This level of funding demonstrates that while ED and related issues are recognized as public health priorities, they still receive a small fraction of overall research support. Ongoing policy attention and expanding public-sector research investment could catalyze more innovation in treatments.
Erectile Dysfunction Market- Market Dynamics
Increasing Prevalence of Lifestyle-Related Conditions Boosts Market Growth
The rising prevalence of lifestyle-related diseases is expected to drive significant growth in the erectile dysfunction (ED) market. Lifestyle-related diseases—such as cardiovascular disorders, diabetes, and obesity—are largely linked to unhealthy habits, including poor diet, physical inactivity, smoking, and excessive alcohol consumption. Factors such as sedentary behavior, stress, and poor dietary patterns are contributing to the global increase in these conditions.
Erectile dysfunction often serves as an early indicator of lifestyle-related diseases, highlighting the need for timely medical intervention and the adoption of healthier lifestyle practices. According to a May 2022 report by the World Obesity Federation, a UK-based non-profit organization, global obesity is projected to affect one billion people by 2030, including one in every five women and one in every seven men, and is expected to rise further to four billion people (51% of the global population) by 2035. This alarming trend underscores the growing prevalence of lifestyle-related diseases and reinforces the potential for sustained growth in the erectile dysfunction treatment market.
Erectile Dysfunction Market- Segmentation Analysis:
The Global Erectile Dysfunction Market is segmented by Application, Therapy Type, Product Type, Distribution Channel and Region.
In terms of application, oral medications are the highest revenue-generating segment of the global erectile dysfunction (ED) drugs market in 2025. This growth is driven by the widespread use of self-administered and cost-effective oral treatments such as Cialis, Stendra, Viagra, and others, as well as increasing collaborations among key market players. For example, in May 2022, Laboratorios Rubio S.A. sold the prescription medication BANDOL (sildenafil oral suspension) to Aspargo Laboratories, Inc., which also signed a distribution agreement with Rubio to continue marketing and promoting BANDOL in the Spanish market.
By distribution channel, online pharmacies have emerged as the most important sales channel in the global ED drugs market. This trend is fueled by the rising prevalence of erectile dysfunction, growing consumer preference for convenient and discreet treatment options, and the launch of advanced digital platforms. For instance, in October 2023, Mangoceuticals, Inc., a company focused on men’s health and wellness products, launched an affiliate marketing program through its newly revamped telemedicine platform. The platform offers specially formulated ED medications under the brand name “Mango”, enabling secure online consultations, prescription fulfillment, and enhanced accessibility for patients.
Erectile Dysfunction Market- Geographical Insights
North America represents a key revenue-generating region in the erectile dysfunction (ED) drugs market, driven by a high prevalence of ED, advanced healthcare infrastructure, and widespread patient awareness. The region benefits from strong R&D capabilities and the presence of leading pharmaceutical companies such as Pfizer Inc. (Viagra) and Eli Lilly and Company (Cialis), which continue to innovate through novel formulations and combination therapies. Factors such as high disposable incomes, improved access to healthcare, and supportive reimbursement policies further sustain long-term market demand.
However, the market faces challenges from patent expirations and the growing availability of generic alternatives, which have intensified competition and influenced pricing strategies. According to Oxford Academic (February 2024), the average prevalence of ED in North America was 20.7%, with a steady rise observed across different age groups and among individuals with comorbid health conditions, underscoring the region’s ongoing clinical and commercial significance.
United States Erectile Dysfunction Market- Country Insights
The United States plays a major role in the North American erectile dysfunction (ED) drug market. Market growth is supported by a large and aging population, the increasing prevalence of lifestyle-related conditions such as diabetes and hypertension, and growing awareness of available ED treatments. Leading pharmaceutical companies, including Pfizer and Eli Lilly, maintain a strong presence, offering medications such as sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra) through multiple distribution channels, including retail pharmacies and online platforms.
For instance, in July 2023, Haleon entered the U.S. over-the-counter ED market through a commercialization agreement for Futura’s drug-free MED3000 gel, which had recently received FDA approval as a de novo medical device. The topical treatment required an initial commercialization investment of $4 million, highlighting ongoing innovation and diversification in the U.S. ED market.
Erectile Dysfunction Market- Competitive Landscape:
Pfizer Inc., Eli Lilly and Company, Bayer AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., and Boston Scientific Corporation are among the leading players in the global erectile dysfunction (ED) market. These companies are actively expanding and diversifying their portfolios through innovations in oral medications, penile implants, and emerging regenerative therapies, including stem cell and shockwave treatments. The market is becoming increasingly competitive as patents for blockbuster drugs such as Viagra and Cialis expire, paving the way for generics and biosimilars.
Strategic collaborations, mergers, and the integration of digital health solutions—such as telemedicine platforms for prescriptions and consultations—are also shaping competitive dynamics. To meet the needs of a growing global patient population, market players are prioritizing innovation, accessibility, and personalized treatment approaches. For example, in February 2024, Petros Pharmaceuticals partnered with 23andMe and a major AI software provider to incorporate advanced technology into its Self-Selection Study for STENDRA (avanafil) OTC approval. The AI-driven platform is designed to improve patient screening accuracy, ensure safe medication access in compliance with FDA and ACNU guidelines, and accelerate Petros’ path toward over-the-counter availability.
Recent Developments:
- March 2024: Johnson & Johnson announced FDA approval of OPSYNVI, a single-tablet combination of macitentan (an endothelin receptor antagonist) and tadalafil (a PDE5 inhibitor), for the chronic treatment of adults with pulmonary arterial hypertension (PAH, WHO Group I) and WHO functional class II–III. OPSYNVI® can be used in treatment-naïve patients or those already receiving an ERA, PDE5 inhibitor, or both.
- July 2024: Aspargo Labs, Inc., a specialty pharmaceutical and MedTech company focused on innovative drug delivery, reported Phase 1 results for ASP-001, an investigational sildenafil oral spray for ED. The study demonstrated that ASP-001 achieves absorption within five minutes—twice as fast as traditional sildenafil tablets—highlighting advancements in rapid-onset ED therapies.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as following:
GLOBAL ERECTILE DYSFUNCTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Bayer AG
- Lilly
- Petros Pharmaceuticals, Inc.
- Pfizer Inc.
- GlaxoSmithKline PLC
- Teva Pharmaceutical
- Sanofi
- Industries Ltd
- Lupin Limited
- Futura Medical
- Cure Pharmaceutical
- Sun Pharmaceutical Industries Ltd
- VIVUS, Inc.
- Auxilium Pharmaceuticals, Inc.
- Others
GLOBAL ERECTILE DYSFUNCTION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Parenteral
- Oral
GLOBAL ERECTILE DYSFUNCTION MARKET, BY THERAPY TYPE- MARKET ANALYSIS, 2019 - 2032
- Drug Therapy
- Device Therapy
GLOBAL ERECTILE DYSFUNCTION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Generic Drugs
- Sildenafil
- Vardenafil
- Alprostadil
- Tadalafil
- Others
- Branded Drugs
- Cialis
- Zydena
- Viagra
- Others
GLOBAL ERECTILE DYSFUNCTION MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
GLOBAL ERECTILE DYSFUNCTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Erectile Dysfunction Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Erectile Dysfunction Market Snippet by Application
2.1.2. Erectile Dysfunction Market Snippet by Therapy Type
2.1.3. Erectile Dysfunction Market Snippet by Product Type
2.1.4. Erectile Dysfunction Market Snippet by Distribution Channel
2.1.5. Erectile Dysfunction Market Snippet by Country
2.1.6. Erectile Dysfunction Market Snippet by Region
2.2. Competitive Insights
3. Erectile Dysfunction Key Market Trends
3.1. Erectile Dysfunction Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Erectile Dysfunction Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Erectile Dysfunction Market Opportunities
3.4. Erectile Dysfunction Market Future Trends
4. Erectile Dysfunction Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Erectile Dysfunction Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Erectile Dysfunction Market Landscape
6.1. Erectile Dysfunction Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Erectile Dysfunction Market – By Application
7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
7.1.2. Parenteral
7.1.3. Oral
8. Erectile Dysfunction Market – By Therapy Type
8.1. Overview
8.1.1. Segment Share Analysis, By Therapy Type, 2024 & 2032 (%)
8.1.2. Drug Therapy
8.1.3. Device Therapy
9. Erectile Dysfunction Market – By Product Type
9.1. Overview
9.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
9.1.2. Generic Drugs
9.1.2.1. Sildenafil
9.1.2.2. Vardenafil
9.1.2.3. Alprostadil
9.1.2.4. Tadalafil
9.1.2.5. Others
9.1.3. Branded Drugs
9.1.3.1. Cialis
9.1.3.2. Zydena
9.1.3.3. Viagra
9.1.3.4. Others
10. Erectile Dysfunction Market – By Distribution Channel
10.1. Overview
10.1.1. Segment Share Analysis, By Therapy Type, 2024 & 2032 (%)
10.1.2. Hospital Pharmacies
10.1.3. Online Pharmacies
10.1.4. Retail Pharmacies
11. Erectile Dysfunction Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Erectile Dysfunction Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Erectile Dysfunction Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Erectile Dysfunction Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Erectile Dysfunction Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Erectile Dysfunction Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Erectile Dysfunction Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Bayer AG
12.2.2. Lilly
12.2.3. Petros Pharmaceuticals, Inc.
12.2.4. Pfizer Inc.
12.2.5. GlaxoSmithKline PLC
12.2.6. Teva Pharmaceutical
12.2.7. Sanofi
12.2.8. Industries Ltd
12.2.9. Lupin Limited
12.2.10. Futura Medical
12.2.11. Cure Pharmaceutical
12.2.12. Sun Pharmaceutical Industries Ltd
12.2.13. VIVUS, Inc.
12.2.14. Auxilium Pharmaceuticals, Inc.
12.2.15. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as following:
GLOBAL ERECTILE DYSFUNCTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Bayer AG
- Lilly
- Petros Pharmaceuticals, Inc.
- Pfizer Inc.
- GlaxoSmithKline PLC
- Teva Pharmaceutical
- Sanofi
- Industries Ltd
- Lupin Limited
- Futura Medical
- Cure Pharmaceutical
- Sun Pharmaceutical Industries Ltd
- VIVUS, Inc.
- Auxilium Pharmaceuticals, Inc.
- Others
GLOBAL ERECTILE DYSFUNCTION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Parenteral
- Oral
GLOBAL ERECTILE DYSFUNCTION MARKET, BY THERAPY TYPE- MARKET ANALYSIS, 2019 - 2032
- Drug Therapy
- Device Therapy
GLOBAL ERECTILE DYSFUNCTION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Generic Drugs
- Sildenafil
- Vardenafil
- Alprostadil
- Tadalafil
- Others
- Branded Drugs
- Cialis
- Zydena
- Viagra
- Others
GLOBAL ERECTILE DYSFUNCTION MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
GLOBAL ERECTILE DYSFUNCTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
